[go: up one dir, main page]

WO2023282918A1 - Appareils et procédés d'occlusion contrôlée temporaire de vaisseaux sanguins - Google Patents

Appareils et procédés d'occlusion contrôlée temporaire de vaisseaux sanguins Download PDF

Info

Publication number
WO2023282918A1
WO2023282918A1 PCT/US2021/041292 US2021041292W WO2023282918A1 WO 2023282918 A1 WO2023282918 A1 WO 2023282918A1 US 2021041292 W US2021041292 W US 2021041292W WO 2023282918 A1 WO2023282918 A1 WO 2023282918A1
Authority
WO
WIPO (PCT)
Prior art keywords
occluder
distal
proximal
occluders
legs
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2021/041292
Other languages
English (en)
Inventor
Raanan Miller
Arnold Miller
Arthur Z. BOOKSTEIN
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Amsel Medical Corp
Original Assignee
Amsel Medical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amsel Medical Corp filed Critical Amsel Medical Corp
Priority to US18/013,995 priority Critical patent/US20230346385A1/en
Publication of WO2023282918A1 publication Critical patent/WO2023282918A1/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods
    • A61B17/12—Surgical instruments, devices or methods for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels or umbilical cord
    • A61B17/122—Clamps or clips, e.g. for the umbilical cord
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods
    • A61B17/12—Surgical instruments, devices or methods for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels or umbilical cord
    • A61B17/128—Surgical instruments, devices or methods for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels or umbilical cord for applying or removing clamps or clips
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods
    • A61B2017/00477—Coupling
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods
    • A61B17/12—Surgical instruments, devices or methods for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels or umbilical cord
    • A61B2017/12004—Surgical instruments, devices or methods for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels or umbilical cord for haemostasis, for prevention of bleeding

Definitions

  • This application relates to methods and devices for temporarily occluding blood vessels, including blood vessels in organs, for example, in situations where one has received an injury and is experiencing significant blood loss.
  • tourniquets generally are useful only for controlling bleeding in limbs, and even then, tourniquets suffer from the disadvantage that they limit blood flow to the entire limb and cannot target individual blood vessels within the limb. It is estimated that of all military wounded who ultimately succumb to their wounds, approximately 10-20% die from blood lossdue to inadequate compression or tourniquet application is a need for more effective temporary blood vessel occlusion techniques and devices for military as well as civilian trauma cases.
  • the present invention provides temporary occlusion devices and techniques that can be deployed percutaneously to temporarily occlude blood vessels including major blood vessels (e.g., arteries) as well as arteries within organs until specialized care can be obtained to surgically control massive hemorrhage following civilian or military trauma.
  • the temporary occluders of the present invention may be used as an internal tourniquet focused on a specific target region or vessel as an alternative to a conventional tourniquet to control major extremity' bleeding following trauma.
  • the temporary occluders of the invention provide a more effective, reliable and highly targeted method to control major blood vessel hemorrhage.
  • the temporary occluder of the present invention may be used even in the presence of soft tissue injury.
  • blood vessels can be occluded by a percutaneously deliverable occlusion device that includes a pair of cooperating occluder elements.
  • a percutaneously deliverable occlusion device that includes a pair of cooperating occluder elements.
  • the damaged blood vessel is accessed with a delivery tube, such as a hypodermic needle, that is pre-loaded with the occlusion device.
  • a delivery tube such as a hypodermic needle
  • EMT emergency medicaltechnician
  • Ultrasound may be used to identify and access a precise target site on the damaged blood vessel where the occluder is to be placed, although other techniques (e.g., tactile sensing) may be employed to sense the presence of a vessel, tubular, or target structure.
  • the occluder may be placed upstream of the location of the hemorrhage, although in some instances it may be desirable to also place an occluder at a downstream location to prevent other feeder vessels from directing blood flow to the hemorrhage site.
  • Deployment involves passing a distal occluder element across the blood vessel (e.g., artery ) so that the distal element is disposed adjacent or against the outer surface of the blood vessel on the far (distal) side of the blood vessel, and then positioning a proximal occluder element adjacent or against the outer surface of the blood vessel on the near (proximal) side of the blood vessel.
  • the degree of occlusion can be dynamically and controllably varied between full occlusion or partial occlusion by varying the degree of applied compression by adjusting the degree to which the proximal and distal occluder elements are urged toward or away from each other.
  • the device may be provided with a plurality of detents or other temporary mechanism to temporarily maintain the relative positions of the occluders without locking the occluders together.
  • the occluder elements may be maintained in a continually adjustable mode or may be locked together to fully occlude the vessel. Means are provided for unlocking a locked occlusion device should that be desired.
  • the proximal occluder is removable through the delivery tube.
  • both of the occluders can be removed through the delivery needle.
  • the occluders can be delivered through a very small deliver ⁇ ' tube or needle that leaves a small puncture hole.
  • hemostasis of the puncture caused by deployment of the temporary' occluder across the blood vessel may be achieved with standard manual compression of the blood vessel, thus minimizing the need for further blood vessel repair.
  • local compression is not adequate other measures, such as cauterization of the tissue, deploying a polymeric sealant, or deploying gauze or a pad, or positioning a coated stent in the vessel or open surgical repair may be used.
  • other means such as cauterization of the tissue, deploying a polymeric sealant, or deploying gauze or a pad, or positioning a coated stent in thevessel, may be used to arrest blood flow.
  • FIG. I is an illustration of the proximal and distal occluder elements.
  • FIG. 2 is an illustration of a delivery device for delivering and deploying the occlusion device.
  • FIG. 3 is an illustration of the distal end of the delivery device as the distal occluder element is delivered.
  • FIG. 4 is an illustration of the distal end of the deliver ⁇ ' device as the proximal occluder element is delivered.
  • FIG. 5 is an illustration of the distal end of the deliver ⁇ ' device when the proximal and distal occluders are brought fully together.
  • FIG. 6 is an enlarged, diagrammatic illustration of the occlusion device in readiness for deployment, and the elements for delivering the occlusion device, partly in section.
  • FIG. 7 is an enlarged, diagrammatic illustration of the components of the delivery device when the distal occluder has been partially ejected out the delivery needle.
  • FIG. 8 is an enlarged, diagrammatic illustration of the components of the delivery device when both the distal and proximal occluders have been deployed pot of the delivery tube.
  • FIG. 9 is an enlarged, diagrammatic illustration of the components of the delivery device when the occluders have been connected and locked together.
  • FIG. 10 is an enlarged, diagrammatic illustration of a modified embodiment in which the occluders have been locked together and in which they may be unlocked to enable removal of the proximal occluder.
  • FIG. 11 is an enlarged, diagrammatic illustration of the modified embodiment of FIG. 10 in which the previously locked occluders have been unlocked.
  • FIG. 12 is an illustration of the unlocked occluders with the proximal occluder having been partially withdrawn back toward the delivery tube.
  • FIG. 13 is an illustration of a modified form of occlusion device in which both occluderscanbe withdrawn back through the delivery tube.
  • FIG. 14 is a photographic triptych illustrating the way the occluders may constrain layers in a serpentine configuration.
  • FIG. 15 is an illustration of a portion of a tube with enhanced flexibility. DFTATT/Fn DESCRIPTION
  • FIG. 1 illustrates one embodiment of a two-piece temporary occlusion device that can be inserted percutaneously through tissue to a target site of a blood vessel, upstream and, in some cases, downstream of ahemorrhaging site.
  • the device includes a proximal occluder 10 and a separate distal occluder 12, both shown in their expanded configurations.
  • the occluders are contained, in tandem and in a low-profile configuration, within the lumen of a delivery tube, such as a needle having an outlet opening at its distal end.
  • Each of the proximal and distal occluders 10, 12 is capable of self-expanding from a low-profile configuration in which it canbereleasably contained in the needle and a diametrically expanded configuration when it is ejected from the needle.
  • FIG. 6 illustrates the occluders contained in the lumen of a delivery needle, shown in phantom at 14. The occluders can be deployed separately and independently on opposite sides of the traumatized vessel and can be urged together to controllably urge the vesselwalls together to fully or partially occlude blood flow and prevent or control blood loss from the damaged vessel.
  • the distal occluder 12 may be formed from a shape memory material such as Nitinol andmay have a tubular body 16 with a plurality of longitudinal slits that define a plurality of legs 18D that, when in the deployed, expanded-diameter configuration, extend radially outward from the body 16 as shown in FIG. 1.
  • the distal occluder 16 is contained in the needle 14 with its legs constrained in a stressed, low profile configuration in which the legs 18D extend longitudinally in a proximal direction. When released from the delivery tube and unstressed, the legs 18D self-extend radially outward to assume the FIG. I configuration.
  • the distal occluder also includes a proximally extending locking post 20 that is attached, at its distal end to the tubular body 16.
  • the proximal end of the post is formed to define one half22 of a somewhat loose mechanical interlock 24 that is releasably interlocked with a complementary second half 26 of the interlock 24 formed on the distal end of an elongate, di tal retention tube 28.
  • the distal retention tube 28 has the same outer diameter as the locking post and extends proximally through the needle 14 to a control handle 30 (FIG. 2) to which it is secured.
  • the distal retention tube 28 may be formed from Nitinol, or other suitable material and, preferably, has at least aportion that is flexible.
  • the locking post also includes a detent groove 36 that circumscribes the post 20 and cooperates with the proximal occluder 10 to lock the occluders together, as described more fully below.
  • the proximal occluder 10 similarly may be formed from a shape memory material such asNitinol and may have a tubular body 38 having aninner diameter dimensioned to slidably fit over the locking post 20 of the distal occluder, and a plurality of distally extending, longitudinal slits that define a plurality of legs 18P that, when in the deployed, expanded-diameter configuration, extend radially outward from the body 16 as shown in FIG. 1.
  • the proximal end of the body 34 is detachably connected to a proximal control tube 42 that, preferably, also may have a flexible portion constructed with transverse slits formed along the length of at least a proximal portion of tube 42, similarly to those on the distal retention tube 28 (FIG. 15), so that itis flexible while also having adequate column, tensile and torsional strength.
  • the proximal occluder 10 is contained in the delivery needle in tandem behind the distal occluder 12 and is formed so that it is contained in the needle 10 with its leg 18P constrained in a low profile and extending distally in readiness to self-deploy to a radially extended configuration when advanced out of the distal end of the needle 14.
  • a control handle 30 for controlling the delivery of the occluders is shown in FIG. 2.
  • the deliver ⁇ ' needle 14 is attached to the handle and is movable longitudinally of the handle so that it can be retracted to expose, eject, and deploy the occluders.
  • Ultrasound imaging may be employed to facilitate placement of the distal tip of the needle.
  • the control handle is manipulated to advance the needle, containing the occluders 10, 12, percutaneously. through intervening tissue to the target region of the involved vessel where it is passed through the vessel to position the distal outlet 46 of the needle on the far (distal) side of the vessel.
  • the needle 14 With the distal outlet 46 of the needle so positioned, the needle 14 is retracted by operating a first trigger 48 on the handle that is operatively associated with the needle to enable longitudinal needle movement relative to the handle and the occluders within the needle. As the needle is retracted the distal occluder is progressively exposed (as suggested in FIG. 6) until it is fully ejected from the needle, at which time the legs 18D of the distal occluder 12 self-deploy to their expanded configuration (FIGS. 4,7).
  • the proximal occluder can be deployed on the near (proximal) side of the vessel by further retraction of the needle 14 by operating the first trigger 48 to progressively expose the proximal occluder until it is fully ejected, at which time the legs 18P of the proximal occluder assume their expanded configuration on the proximal side of the vessel.
  • the proximal occluder 10 can be advanced distally, by operating a second trigger 58, which is operatively associated, through the proximal control tube 42, with the proximal occluder 10, to clamp the vessel between the proximal and distal occluders 10, 12.
  • the occluders include a locking mechanism by which they can be locked together, for example, to fully occlude the vessel.
  • the locking mechanism may include a notch 36, such as a detent groove formed on the locking post 20 of the distal occlude that defines a shoulder 52 at its proximal end and may define a proximally tapering conoid 54 at its distal end.
  • the proximal occluder may include one or more tangs 56 formed in the wall of the tubular body 38, the tang(s) having an unstressed configuration that projects inwardly into the lumen of the body 38 but is pushed back into alignment with the tubular wall of occluder 10 when the proximal occluder is disposed about the outer diameter of the locking post 20 of the distal retention tube 28.
  • the proximal occluder may be advanced over the locking post 29 to align the tang 56 with the groove 50 that enables the tang 56 to spring to its unstressed configuration to self-engage the shoulder of the groove 36, thus locking the occluders together in a vessel- clamping configuration.
  • means may be provided for unlocking the occluders.
  • the invention enables the medical personnel to control the degree of vessel occlusion by varying intermittently the degree of occlusion applied to the vessel.
  • the degree of blood flow out of the vessel can be balanced sufficiently with the degree of occlusion to avoid clot formation while minimizing blood loss until the patient can be transported to a facility where the special care to treat thetrauma is available.
  • the device may be provided with a tubular lock disabling shaft 50 that is slidably disposed about the proximal control tube 42 and the locking tube 20.
  • the disabling shaft 50 extends proximally through the control handle 30 so that its longitudinal position can be controlled by the medical attendant, as by a handle 62 (FIG. 2).
  • FIGS. 6-8 illustrate the device with the disabling tube in a distal position in which it overlies the detent groove 36 of the locking post 20, thus preventing the tang 56 from engaging with the groove 36 while enabling the proximal occluder to slide over the disabling tube 50.
  • the disabling tube also serves to overlie the interlock 24 to ensure that the first and second halves 22, 26 of the interlock 24, which are loosely formed to be disengaged by manipulation of the retention tube 28, do not separate inadvertently.
  • the inner diameter of the disabling tube 50 is such that it can slide closely over the locking tube 20 and the distal retention tube 28.
  • the outer diameter of the disabling tube 50 is slightly less than the inner diameter of the tubular body of the proximal occluder to enable the proximal occluder to slide over the disabling tube 0.
  • the relative positions of the proximal and distal occluders can be variably adjusted to optimally control the degree of occlusion without concern of the occluders becoming locked inadvertently. If, at some point, it is desired to lock the occluders to fully occlude the vessel, the disabling tube 50 can be retracted by handle 62 to expose the groove 36 after which the proximal occluder 10 can be advanced distally by operating the second trigger 58 until the tang 56 engages the groove 36.
  • connection between the proximal occluder and the control shaft may be frangible to permit it to be broken away, such as, for example, by attaching the control tube 28 to the proximal occluder only at a few points as by tack welding, brazing or by other means ( threaded connection). Other types of connections may be used to permit the separation.
  • the device may be modified as shown in FIGS.10-12, by increasing the diameter of a portion 60 of the locking post immediately below the conoid surface 54 to have an outer diameter substantially equal to that of the disabling tube 50 and so that it can closely slide within the tubular body 38 of the proximal occluder 10.
  • the distal retention tube 28 can be retracted proximally while maintaining the position ofthe proximal occluder, thus advancing the distal occluder and its locking post 20 proximall y relative to the proximal occluder. That causes the conoid portion 54 of the groove 36 to engage the tang 56 to urge the tang radially outward into alignment with the wall of the proximal occluder body, thus disengaging those locking elements. Then, as shown in FIG.
  • the disabling tube 50 may be advanced distally to locate its distal end adjacent the outermost portion of the conoid 54 so that the disabling tube 50 and post portion 60 present a continuous outer diameter over which the proximal occluder may retracted, either to reestablish blood flow control or to entirely remove the proximal occluder 10 as suggested in FIG. 12. It may be noted that the slight retraction of the retention tube 28 will tend to increase the force applied to the tissue.
  • the unaligned legs 18P, 18D of the occluders are relatively resilient and may yield without applying excessive force to the tissue.
  • the legs 18P, 18D when in their expanded configurations, extend at an angle from their respective bodies that define a concave, conoid configuration in which the concavities of the occluders face each other.
  • FIG. 13 illustrates a modified embodim ent of the invention in w hich the legs 18P, 18D of both occluders, when in their expanded configurations, define concavities that face in a distal direction.
  • proximal and distaloccluders may cooperate to occlude the vessel in a relatively atraumatic manner that reduces the risk of further damage to the vessel.
  • the occluders are configured so that when they are deployed, they can be oriented so that the legs 18P, 18D of the proximal and distal occluders 10,
  • FIG. 14 illustrates the arrangement of the legs 18P, 18D of the proximal and distal implants in which the out-of-registry legs are sufficiently interdigitated so that they do not effect a direct compressive clamping of the tissue but, instead, engage the tissue to constrain the tissue in a serpentine configuration extending at least partly about the axis of the occluder in a generally circumferential direction.
  • the legs of one of the implants are out of registry w ith those of the other impl ant so that when viewed in plan, the legs of one implant lie between the legs of the other.
  • FIG. 5 illustrates the interdigitation of the occluder legs in the absence of tissue. Even if the thickness or other characteristic of the clamped vessel is such that the occluder legs do not actually achieve interdigitation, the legs nonetheless apply oppositely directed forces at circumferentially spaced locations about the axis of the occluders the clamped tissue layer. Such application of clamping force is less likely to cause additional tissue injury than direct clamping.
  • the legs of the occluders are not plastically formed but are in an elastic state to act as springs that can adjust to the tissue properties such as thickness, stiffness, etc. while still providing sufficient force to compress the vessel or tissue without crushing the tissue and causing further damage.
  • the legs of one or both occluders may be formed to extend at an acute angle to the occluder axis to define a conical configuration. This provides an additional means by which the clamping forces can be adjustably controlled. By selecting, during manufacture, a particular cone angle defined by the expanded legs as well as their stiffness, the characteristics of the serpentine pattern can be varied.
  • the entire apparatus can be contained in a hollow needle or delivery tube with an outer diameter of less than 1.7 mm or less than 1.5 mm.
  • the proximal control tube 28 may have an outer diameter of about 0.7 mm; the outer diameter of tube 42 may be about 1.3 mm with an inner diameter of about 1.0 mm; the inner diameter of tube 50 is just slightly larger than 0.7 mm with an outer diameter of just slightly smaller than 1 mm.
  • the depth of the locking region 36 may be about 0.1 mm.
  • FIG 14 shows three photographs of serpentine folds formed in a simulated blood vessel. Those folds or ripples extend radially beyond the ends of the legs IBP, 18 D, effectively extending the radial extent of the closure and defining a circumferential band with a diameter greater than that of the occluders.
  • a two-part occluder as described above and having legs that define a diameter of 5.5 mm may be able to occlude vessels that are over 7 mm (and even equal or greater than 1 cm) in diameter.
  • the ability of the two- occluder to cause serpentine ripples beyond the diam eter of the legs 18 of the device enables the device to be at least partly effective and, possibly fully effective, even if the needle misses and does not transfix the vessel but is sufficiently close to the vessel so that some of the legs, or at least some of the circumferential band defined by the serpentine ripples overlies at least a portion, and possibly all, of the width of the vessel.
  • the invention thus provides a margin of error and may- enable sufficient temporary occlusion to be achieved even if the target vessel is not transfixed by the needle.

Landscapes

  • Health & Medical Sciences (AREA)
  • Surgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Vascular Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Reproductive Health (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Surgical Instruments (AREA)

Abstract

La présente invention concerne des dispositifs et des techniques d'occlusion temporaire qui peuvent être déployés par voie percutanée pour occlure temporairement des vaisseaux sanguins comprenant des vaisseaux sanguins majeurs (par exemple, des artères) ainsi que des artères à l'intérieur d'organes jusqu'à ce que des soins spécialisés puissent être obtenus pour maîtriser chirurgicalement une hémorragie massive suite à un traumatisme civil ou militaire. Les dispositifs d'occlusion temporaire de la présente invention peuvent être utilisés en tant que garrot interne focalisé sur une région ou un vaisseau cible spécifique constituant une variante à un garrot classique pour contrôler un saignement majeur d'une extrémité suite à un traumatisme. Les dispositifs d'occlusion temporaire de l'invention peuvent fournir un procédé plus efficace, fiable et hautement ciblé pour contrôler une hémorragie d'un vaisseau sanguin majeur. En outre, contrairement à un garrot classique, le dispositif d'occlusion temporaire de la présente invention peut être utilisé même en présence d'une lésion de tissu mou.
PCT/US2021/041292 2020-07-09 2021-07-12 Appareils et procédés d'occlusion contrôlée temporaire de vaisseaux sanguins Ceased WO2023282918A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US18/013,995 US20230346385A1 (en) 2020-07-09 2021-07-12 Apparatus and method for temporary occlusion of blood vessels

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202163050099P 2021-07-09 2021-07-09
US63/050,099 2021-07-09

Publications (1)

Publication Number Publication Date
WO2023282918A1 true WO2023282918A1 (fr) 2023-01-12

Family

ID=84801901

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2021/041292 Ceased WO2023282918A1 (fr) 2020-07-09 2021-07-12 Appareils et procédés d'occlusion contrôlée temporaire de vaisseaux sanguins

Country Status (1)

Country Link
WO (1) WO2023282918A1 (fr)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030139819A1 (en) * 2002-01-18 2003-07-24 Beer Nicholas De Method and apparatus for closing septal defects
US20110082495A1 (en) * 2009-10-02 2011-04-07 Ruiz Carlos E Apparatus And Methods For Excluding The Left Atrial Appendage
US20130289618A1 (en) * 2004-05-07 2013-10-31 W.L. Gore & Associates, Inc. Catching Mechanisms for Tubular Septal Occluder
US20190365547A1 (en) * 2018-04-12 2019-12-05 Amsel Medical Corporation Method and apparatus for fixating endovascular prostheses

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030139819A1 (en) * 2002-01-18 2003-07-24 Beer Nicholas De Method and apparatus for closing septal defects
US20130289618A1 (en) * 2004-05-07 2013-10-31 W.L. Gore & Associates, Inc. Catching Mechanisms for Tubular Septal Occluder
US20110082495A1 (en) * 2009-10-02 2011-04-07 Ruiz Carlos E Apparatus And Methods For Excluding The Left Atrial Appendage
US20190365547A1 (en) * 2018-04-12 2019-12-05 Amsel Medical Corporation Method and apparatus for fixating endovascular prostheses

Similar Documents

Publication Publication Date Title
US12102332B2 (en) Methods and apparatus for clamping tissue and occluding tubular anatomical structures
US10918391B2 (en) Method and apparatus for clamping tissue and occluding tubular body lumens
EP2745812B1 (fr) Contraintes de diamètre repositionnable
EP2663244B1 (fr) Appareil pour fixer des couches de tissu ensemble
US20050125022A1 (en) Blood vessel occlusion device
JP2011500283A (ja) 開放手術で設置される脈管導管及び送達システム
IL144324A (en) Apparatus for compressing body tissue
EP2863811B1 (fr) Dispositifs d'occlusion de vaisseau
CN106659503B (zh) 用于阻塞血管和/或其它管状结构的方法和器械
US20230346385A1 (en) Apparatus and method for temporary occlusion of blood vessels
WO2023282918A1 (fr) Appareils et procédés d'occlusion contrôlée temporaire de vaisseaux sanguins
EP3886731B1 (fr) Appareil pour fermeture de vaisseaux
US11484306B2 (en) Apparatus and methods for occlusion of blood vessels
US20250107808A1 (en) Methods and apparatus for clamping tissue and occluding tubular anatomical structures
US20240366230A1 (en) Apparatus and methods for temporary occlusion of blood vessels
US12070222B2 (en) Apparatus and method for temporary occlusion of blood vessels
WO2013152283A1 (fr) Procédé et appareil pour occlure un vaisseau sanguin

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 21949503

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 21949503

Country of ref document: EP

Kind code of ref document: A1